Simvastatin-Encapsulated Topical Liposomal Gel for Augmented Wound Healing: Optimization Using the Box-Behnken Model, Evaluations, and In Vivo Studies

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Jun 27

PMID 38931364

Authors

Mohamed Rahamathulla

Rahul Pokale

Yousef Al-Ebini

Riyaz Ali M Osmani

Kamal Y Thajudeen

Ravi Gundawar

Mohammed Muqtader Ahmed

Syeda Ayesha Farhana

Thippeswamy Boreddy Shivanandappa

Affiliations

Soon will be listed here.

Abstract

Statins function beyond regulating cholesterol and, when administered systemically, can promote wound healing. However, studies have yet to explore the topical use of statins for wound healing. The present study demonstrated the topical administration of SIM and aimed to formulate, evaluate, and optimize Simvastatin (SIM)-encapsulated liposome gel carrier systems to facilitate successful topical wound healing. Liposomes containing SIM were formulated and optimized via a response surface methodology (RSM) using the thin-film hydration method. The effects of formulation variables, including the 1,2-dioleoyloxy-3-trimethylammoniumpropan (DOTAP) concentration, Span 80 concentration, and cholesterol concentration, on zeta potential (mV), entrapment efficacy (%), and particle size (nm) were studied. The optimized liposome formulation (F-07) exhibited a zeta potential value of 16.56 ± 2.51 mV, revealing robust stability and a high SIM encapsulation efficiency of 95.6 ± 4.2%, whereas its particle size of 190.3 ± 3.3 nm confirmed its stability and structural integrity. The optimized liposome gel demonstrated pseudoplastic flow behavior. This property is advantageous in topical drug delivery systems because of its ease of application, improved spreadability, and enhanced penetration, demonstrating prolonged SIM release. The assessment of the wound healing efficacy of the optimized liposomal gel formulation demonstrated a substantial decrease in wound size in mice on the sixteenth day post-wounding. These findings suggest that the use of liposomal gels is a potential drug delivery strategy for incorporating SIM, thereby augmenting its effectiveness in promoting wound healing.

References

Hasanein Asfour M, Elmotasem H, Mostafa D, Salama A . Chitosan based Pickering emulsion as a promising approach for topical application of rutin in a solubilized form intended for wound healing: In vitro and in vivo study. Int J Pharm. 2017; 534(1-2):325-338. DOI: 10.1016/j.ijpharm.2017.10.044. View

Wieber A, Selzer T, Kreuter J . Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. Eur J Pharm Biopharm. 2011; 80(2):358-67. DOI: 10.1016/j.ejpb.2011.11.008. View

Bragagni M, Mennini N, Ghelardini C, Mura P . Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. J Pharm Pharm Sci. 2012; 15(1):184-96. DOI: 10.18433/j3230m. View

Shi J, Ma F, Wang X, Wang F, Liao H . Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design. J Liposome Res. 2012; 22(4):270-8. DOI: 10.3109/08982104.2012.690159. View

Aly U, Abou-Taleb H, Abdellatif A, Tolba N . Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose. Drug Des Devel Ther. 2019; 13:1567-1580. PMC: 6512793. DOI: 10.2147/DDDT.S198413. View

Karimi M, Gheybi F, Zamani P, Mashreghi M, Golmohammadzadeh S, Darban S . Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. Int J Pharm. 2020; 580:119211. DOI: 10.1016/j.ijpharm.2020.119211. View

Hemmingsen L, Julin K, Ahsan L, Basnet P, Johannessen M, Skalko-Basnet N . Chitosomes-In-Chitosan Hydrogel for Acute Skin Injuries: Prevention and Infection Control. Mar Drugs. 2021; 19(5). PMC: 8150996. DOI: 10.3390/md19050269. View

Thangamani S, Mohammad H, Abushahba M, Hamed M, Sobreira T, Hedrick V . Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Sci Rep. 2015; 5:16407. PMC: 4639749. DOI: 10.1038/srep16407. View

He R, Ye X, Li R, Chen W, Ge T, Huang T . PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU. J Liposome Res. 2016; 27(2):161-170. DOI: 10.1080/08982104.2016.1191021. View

10.

Muppidi K, Pumerantz A, Wang J, Betageri G . Development and stability studies of novel liposomal vancomycin formulations. ISRN Pharm. 2012; 2012:636743. PMC: 3302012. DOI: 10.5402/2012/636743. View

11.

Xie P, Dolivo D, Jia S, Cheng X, Salcido J, Galiano R . Liposome-encapsulated statins reduce hypertrophic scarring through topical application. Wound Repair Regen. 2020; 28(4):460-469. DOI: 10.1111/wrr.12811. View

12.

Casula L, Zidar A, Kristl J, Jeras M, Kralj S, Fadda A . Development of Nanofibers with Embedded Liposomes Containing an Immunomodulatory Drug Using Green Electrospinning. Pharmaceutics. 2023; 15(4). PMC: 10143873. DOI: 10.3390/pharmaceutics15041245. View

13.

Dragicevic N, Krajisnik D, Milic J, Fahr A, Maibach H . Development of hydrophilic gels containing coenzyme Q-loaded liposomes: characterization, stability and rheology measurements. Drug Dev Ind Pharm. 2018; 45(1):43-54. DOI: 10.1080/03639045.2018.1515220. View

14.

Raposio E, Libondi G, Bertozzi N, Grignaffini E, Grieco M . Effects of Topic Simvastatin for the Treatment of Chronic Vascular Cutaneous Ulcers: A Pilot Study. J Am Coll Clin Wound Spec. 2017; 7(1-3):13-18. PMC: 5196493. DOI: 10.1016/j.jccw.2016.06.001. View

15.

El Zaafarany G, Awad G, Holayel S, Mortada N . Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010; 397(1-2):164-72. DOI: 10.1016/j.ijpharm.2010.06.034. View

16.

Ahmed L, Hassanein K, Mohamed F, Elfaham T . Formulation and evaluation of simvastatin cubosomal nanoparticles for assessing its wound healing effect. Sci Rep. 2023; 13(1):17941. PMC: 10589326. DOI: 10.1038/s41598-023-44304-2. View

17.

Costa P, Sousa Lobo J . Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13(2):123-33. DOI: 10.1016/s0928-0987(01)00095-1. View

18.

Zorzi G, Schuh R, Maschio V, Brazil N, Rott M, Teixeira H . Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba. Colloids Surf B Biointerfaces. 2018; 173:725-732. DOI: 10.1016/j.colsurfb.2018.10.044. View

19.

Beaulac C, Hawari J, Lagace J . In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. J Microencapsul. 1997; 14(3):335-48. DOI: 10.3109/02652049709051137. View

20.

Boyapati L, Wang H . The role of stress in periodontal disease and wound healing. Periodontol 2000. 2007; 44:195-210. DOI: 10.1111/j.1600-0757.2007.00211.x. View